Here we are pleased to demonstrate how we try to find an answer to all these questions, what dilemmas we face in doing so, the results we achieve, and where we could possibly encounter difficulties. We share the lessons we learn, the new insights we gain and, above all, we look towards the future.
Post-corona recovery catalyst for green bond market
The market for green bonds is recovering now that countries are combining economic recovery and sustainability, writes Wilfried Bolt.
05 aug 2020
Blog
Assetmanagement
PGGM’s Private Equity Annual Responsible Investment Report 2019 is published
PGGM is committed to investing responsibly.
14 jul 2020
Blog
Assetmanagement
Forests as building blocks for a climate neutral economy
Trees are our natural allies in coping with the current climate and biodiversity crisis, Brenda Kramer thinks.
19 jun 2020
Blog
Assetmanagement
Economic recovery and pension investing in the EU
The EU High Level Forum on Capital Markets Union delivered its final report in extraordinary circumstances. PGGM CIM and member of HLF Eloy Lindeijer shares his main take aways.
29 apr 2020
Blog
Assetmanagement
Listed companies that take up their social responsibility
In this Corona crisis Dutch DSM shows why it has made a name as a responsible company that understand societal needs, Marek Troszczynski van Genderen writes.
14 apr 2020
Blog
Assetmanagement
Let’s look beyond the crisis: what do you see?
The corona crisis is compelling us to ask fundamental questions: how can we make our world sustainable so that we don’t stumble from crisis to crisis? Brenda Kramer on the EU taxonomy.
08 apr 2020
Blog
Assetmanagement
Impactful companies: stable investment in times of crisis
PFZW investments in listed companies that have been selected for both their societal and financial returns perform relatively better than the broader index, Martin Eijgenhuijsen and Dirk-Jan Verzuu conclude.
01 apr 2020
Blog
Assetmanagement
Access to health care in exceptional times
Investors finance the different links that together form the global production chains for medical devices, pharmaceutical and other care-related products. Governments and companies must ensure that these products are available all over the world.
By using our website, you also accept our cookies. Cookies contain a (unique) number and no personal details. We cannot identify you personally through the cookies, nor can we use them to identify you on the websites of third parties.